The SP was 20c in Jan. Was this tortuous path -- far from complete -- the best route to 46c? Or do you think they could have managed to get from 20c up to 50c in less risky fashion? (Eg by not delisting.) What odds do you place on US$6 happening vs not happening? And when you factor that in, is the upside well priced? Or is it an expensive risk for an unimpressive outcome?
Ann: G Medical Files Registration Statement with US SEC, page-54
-
- There are more pages in this discussion • 188 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)